Cerebrotendinous Xanthomatosis

This is a rare genetic condition that affects how your body processes cholesterol. It causes cholesterol to build up in your tendons and other tissues, leading to swelling. It also causes early cataracts and can lead to problems with your brain and nerves.

ConditionRare Disease

What people with Cerebrotendinous Xanthomatosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis?

NameHow it went

About Cerebrotendinous Xanthomatosis

What It Is

Cerebrotendinous xanthomatosis (CTX) is a rare inherited condition in which the body cannot properly turn cholesterol into bile acids, the substances the liver makes to help digest fat. Instead, a cholesterol-like fat called cholestanol builds up slowly in the brain, nerves, tendons, eyes and other tissues. The name reflects where the deposits matter most: "cerebro" for the brain and "tendinous" for the tendons, where fatty lumps called xanthomas can form. CTX usually begins in childhood with problems that seem unrelated: long-lasting diarrhea, cataracts (clouding of the eye's lens) at an unusually young age, and sometimes learning difficulties. In adulthood, firm lumps may appear on the Achilles tendons or other tendons, and neurological problems can develop, including unsteady walking, stiff or weak legs, slurred speech, numbness in the hands and feet, seizures, memory and thinking decline, and mood or behavior changes. CTX matters because it is treatable, and treatment works best when it starts before lasting nerve damage has occurred.

Causes & Risk Factors

CTX is caused by changes (variants) in both copies of a gene called CYP27A1, which carries instructions for an enzyme needed to make one of the main bile acids, chenodeoxycholic acid. Without that enzyme, the body keeps pushing cholesterol down an alternative pathway that produces cholestanol and bile alcohols. Blood cholesterol is usually normal, which is one reason the condition is easy to miss. CTX is inherited in an autosomal recessive pattern: a person has CTX only when they inherit a non-working copy of the gene from each parent. Parents who each carry one copy usually have no symptoms, and each of their children has a one-in-four chance of having CTX. The condition is more common when parents are related by blood and in some communities, including people of Moroccan Jewish descent. Nothing a person did or did not do causes CTX, and diet does not trigger it.

How It's Diagnosed

Because the early signs are spread across different parts of the body, CTX is often diagnosed years or even decades after symptoms begin. A combination of clues should raise suspicion, especially cataracts in a child or young adult together with chronic diarrhea that started in childhood. Tendon lumps in someone with normal cholesterol, unexplained walking problems or leg stiffness, and a brain MRI (magnetic resonance imaging) scan showing changes in the cerebellum (the part of the brain that coordinates movement) are other important clues. A prolonged, unexplained yellowing of the skin in a newborn can be an early sign. The key blood test measures cholestanol, which is high in CTX even when ordinary cholesterol is normal. A urine test for bile alcohols can support the diagnosis. Genetic testing that finds disease-causing variants in both copies of the CYP27A1 gene confirms it. Once someone is diagnosed, their brothers and sisters should be tested even if they feel well, since starting treatment before symptoms appear offers the best chance of preventing them.

Treatment Options

The main treatment is chenodiol, also called chenodeoxycholic acid (CDCA), a bile acid taken by mouth that replaces the one the body cannot make. Supplying it signals the liver to slow down the faulty pathway, which sharply lowers cholestanol in the blood and stops further buildup. In the US, Ctexli (chenodiol) is approved by the Food and Drug Administration (FDA) for adults with CTX and is usually taken three times a day. Children are treated with weight-based doses under a specialist's care. Treatment is lifelong. What chenodiol can do depends heavily on timing. It usually ends the chronic diarrhea and can stabilize or improve problems with thinking, walking and balance. In a long-term study, people who started treatment before about age 24 saw their neurological symptoms resolve and did not develop new ones, while many who started later continued to decline, with parkinsonism (slowness, stiffness and tremor) responding especially poorly. Chenodiol generally does not shrink tendon lumps or reverse cataracts that have already formed. The evidence comes from long-term observational studies rather than placebo-controlled trials, which are hard to run in a disease this rare. Chenodiol can occasionally injure the liver, so liver blood tests are checked before starting and then regularly, and the dose may be paused or lowered if results rise. For people who cannot take chenodiol, cholic acid, another bile acid, has been used as an alternative, though evidence is more limited. Other care is aimed at specific problems: cataract surgery, physical therapy for walking and balance, treatment for seizures, depression or parkinsonism, and attention to bone strength.

What to Expect

Without treatment, CTX tends to worsen over years, though the pace and pattern vary widely from person to person, even within the same family. With treatment started early, many people remain stable and live independently. For people diagnosed later, the realistic goal is usually to halt or slow further decline, and some lost function may not return. Blood cholestanol can take a long time, sometimes years, to fall into the normal range, and any improvement in symptoms also tends to unfold gradually. Living with CTX usually means taking chenodiol every day and keeping up regular follow-up, typically yearly, with a team that may include a neurologist, a metabolic or genetics specialist and an eye doctor. Follow-up often includes cholestanol and liver blood tests, neurological and memory assessments, and periodic brain imaging. Because CTX can weaken bones and is linked to earlier hardening of the arteries, bone density scans and attention to heart health are often part of long-term care. Genetic counseling can help relatives understand their own risk and decide about testing.

When to Seek Help

Ask about testing for CTX if a child or young adult has cataracts together with long-standing diarrhea, if tendon lumps appear despite normal cholesterol, or if a brother or sister has been diagnosed. For someone already diagnosed, raise new or worsening problems with walking, balance, speech, memory, mood or seizures with the care team, since they may call for a change in treatment. If you take chenodiol and notice yellowing of the skin or eyes, dark urine, pain in the upper abdomen, unusual bruising or bleeding, or itching with nausea and fatigue, stop the medicine and contact your prescriber right away, as these can be signs of liver injury.

Questions to Ask Your Doctor

  1. 1.Which tests confirmed the diagnosis, and should my siblings or other relatives be tested?
  2. 2.What can treatment realistically improve for me now, and what is it most likely to prevent?
  3. 3.How often will we check my cholestanol, liver tests, bones and brain imaging, and what results would change the plan?
  4. 4.Which specialists should be part of my care, and what therapies could help with walking, balance or memory?
  5. 5.If I am planning a pregnancy, how should my treatment be managed?

Last reviewed • Oct 2026

Educational content, not medical advice.